Biotech Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business Update
Acceptance rate of optomap plus Medical Retinal Exam grows
May 18th, 2006
Optos, Inc., a wholly-owned subsidiary of Optos plc (OPTS), announced that the acceptance rate among practitioners for its optomap plus Medical Retinal Exam, a procedure for medically necessary disease management and follow-up, is growing. Practitioners will continue to perform the core optomap Retinal Exam for wellness screening on patients presenting for comprehensive eye exams. However, for those patients with complaints that either may indicate pathology, have signs or symptoms of pathology or have a medical history of pathology, an optomap plus Medical Retinal Exam is available. "The optomap plus Medical Retinal Exam allows a physician to tune...
Source: Biotech Business Week (2006-05-18)
|
